DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 18 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q1 2023$100.0%10.0%0.00%
Q4 2022$1010.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$0
-100.0%
1
-100.0%
0.00%
-100.0%
Q3 2021$9,950,000
-2.5%
1,000,0000.0%0.19%
+7.2%
Q2 2021$10,200,000
+1.9%
1,000,0000.0%0.18%
-13.8%
Q1 2021$10,012,000
-6.1%
1,000,0000.0%0.21%
-0.5%
Q4 2020$10,660,0001,000,0000.21%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q2 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 400,000$4,264,0001.59%
Endurant Capital Management LP 195,000$2,079,0000.75%
CVI Holdings, LLC 355,000$3,784,0000.71%
Wealthspring Capital LLC 129,880$1,385,0000.69%
Sio Capital Management, LLC 300,000$3,198,0000.66%
Monashee Investment Management LLC 300,000$3,198,0000.42%
Sage Mountain Advisors LLC 95,970$1,023,0000.34%
683 Capital Management, LLC 600,000$6,396,0000.30%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 200,000$2,138,0000.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$2,132,0000.23%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders